Chris Ozanian

"...These challenges have profoundly impacted media planning and buying."  + "Nearly nine in ten ad buyers report shifts in personalization tactics, ad spend and their mix of first-, second- and third-party data.  + "Over three-in-four cite selection changes in media channels and KPIs, along with more seller-direct deals." "...To adapt, companies are investing significantly in training staff on data privacy (78%), creating dedicated teams for business transformation and seeking external expertise through new hires and consultancy partnerships."  "Analytics departments are being impacted the most, along with legal and compliance, ad operations and programmatic teams, due to their heavy reliance on data."

7

Thoughts on this? >> FCC explicitly prohibits fast lanes, closing possible net neutrality loophole >> Comment below! >>> lqventures.com #digitalhealth #socialmedia #digitalmarketing #AI #industry40 #mhealth #healthtech #IoT

1

Thoughts on this? >> All of the iPhone 16 colors just leaked. Here’s what’s coming >> Comment below! >>> lqventures.com #digitalhealth #socialmedia #digitalmarketing #AI #healthtech #IoT #mhealth #industry40

1

Another great episode! Tips to address challenges and reframe, acknowledge & influence skeptical audiences.

3

A memorable brand has a simple message. Matt Lyles and I discuss the role of clarity in a simplicity-driven brand. https://lnkd.in/gdf6bVeU

1

2 Comments

Build rather than buy an RBQM solution? Really? There must be something in the air at #OCTEastCoast because we've just had another "interesting" conversation, this time with a mid-sized Sponsor. They are building their own #RBQM solution. Really? Why? Would you build a new CTMS or EDC? Would you go to the time, expense, hassle, and risk of developing a new system when you can buy a proven, validated, secure, and scalable solution that's ready to go? A solution you don't have to maintain, managed by experts and that is constantly evolving with the latest from the sector. Even big Sponsors are coming to us and saying their attempts to develop in-house RBQM solutions haven't delivered the results they want or need, and are too expensive to maintain. Build rather than buy an RBQM solution? Really? The numbers just don't add up.

12

Step into the future of inclusive patient recruitment with Parexel's very own Patrick Grimes at PharmaSUG! Join us for "Leadership Skills LS-134: Recruiting Neurodivergent Candidates using the Specialisterne Approach." Learn how embracing diversity can enrich your team's culture and impact. Date for the diary. May 20th Monday, 8:30 AM - 8:50 AM Key Ballroom 10 If you want to work in an inclusive environment, that is always patient-focused, dive deeper here: https://jobs.parexel.com #ParexelWithHeart #LeadershipDevelopment #InclusivePatientRecruitment #StatsProgramming #StatisticalProgramming #PharmaSUG

2

As clinical research professionals, we tirelessly work towards the common goal of ensuring safety and efficacy in every aspect of our work. But the rapidly changing demands of our industry create challenges and leave us feeling like we’re on a rollercoaster ride. That’s why I love hearing from industry colleagues like Stacy Hurt, who champion keeping the patient at the heart of what we do despite the challenges. So, need some inspiration today? Check out what these talented professionals have to say about keeping patients at the forefront. ♥ The best advice I learned is that embedding patient-centricity involves an ongoing, never-ending curiosity and pursuit of understanding each patient as if you are walking in their skin. To quote Harper Lee's To Kill a Mockingbird, "You never understand a person until you climb in their skin and walk around in it." Keeping patients at the heart of what we do starts with understanding them! #patientsfirst #patientcentricity #clinicaltrials #clinicalresearch Stacy Hurt 🌻 Parexel

1

❔ How do we position regional and community sites for success and mitigate risks for sponsors? ❔ In our new Oncology report, Parexel’s Karen McIntyre and Angela Hirst weigh in on why the traditional approach to site selection in oncology has created bottlenecks at major centers, potentially limiting patient access to life-changing therapies. 🚧 That’s why Parexel is bridging the gap by partnering with regional and community sites while still ensuring the high-quality standards of academic centers. Find out how: https://lnkd.in/g7Tzd3t2 #ResearchSites #Oncology #NovelInsights

4

How do we position regional and community sites for success and mitigate risks for sponsors? In our new Oncology report, Parexel’s Karen McIntyre and Angela Hirst weigh in on why the traditional approach to site selection in oncology has created bottlenecks at major centers, potentially limiting patient access to life-changing therapies. That’s why Parexel is bridging the gap by partnering with regional and community sites while still ensuring the high-quality standards of academic centers. Find out how: https://lnkd.in/gfibr9S4 #ParexelBiotech #ResearchSites #Oncology #NovelInsights

2

Check out the latest MM+M #TrendTalks Takeaways. Interesting perspective on AI and Omnichannel marketing.

21

At DIA, all the sponsored presentations are titled "Innovation Theater". Is this just a poor choice of words? Or a brutally clear-eyed statement that we should only expect play-acting at innovation?

14

1 Comment